The immuno lobulins and coproantibody formation & infants after artificial intestinal colonization with E. coli 083. Protective effect of orally administered antibody.
body against E. coli 083 increased between 4-16 weeks. The colonization did not influence significantly the serum irmunoglobulin levels. In colonize8 bottle-fed i q t s the level of copror antibodies was significantly higher from 4 up to 16 weeks than in controls, in breast-fed colonized infants between 2-6 weeks. The colonitation induced a formation of secretory IgA in bat tle-fed infants from the 4th up to the 16th week. In breast-fed infants this effect was masked due to passive transfer of I P ria maternal milk. In 24 cases of d arrhoea caused by E. coli an antibody against E.coli 055,0111 and 026 was administered orally 7 times, 2ml/kg.In 19 infants the stools turned to normal; F.A.Hommes ,c. ~endien', J. ~.~l e m a * ,~e~a r t m e n t s of P e d i a t r i c s and Pathology,School of Medicine, University of Groningen. The Netherlands. ~h o s~h o e n b l~y r u v a t e carboxykinase deficiency. Inborn e r r o r s of 3 of t h e 4 enzymes s p e c i f i c f o r gluconeogenesis a r e known. The present r e p o r t describes a deficiency of t h e 4th enzyme phosphoenolpyruvate carboxykinase (PEP-CK). characterized by severe hypoglycemia and extreme f a t t y ci!anges of l i v e r and kidney. A l i v e r biopsy, taken immediately a f t e r death, demonstrated increased a c t i v i t i e s of glucose-6-phosphatase, fructose-1,6-diphosphatase and pyruvate carboxylase (40.6,15.9 and 3.3 pmoles p e r min. p e r g W.W. respectively) and a decreag ed a c t i v i t y of PEP-CK (0.7 urnoles p e r min. p e r g w.w.). The low a c t i v i t y of PEP-CK can explain the hypoglycemia. Light and e l e c t r o n microscopy showed extreme f a t t y changes of t h e l i v e r and of the proximal tubuli of the kidney. The l i v e r contained 55% (of wet weight) of chloroformmethanol e x t r a c t a b l e material. The f a t t y acid composition of these l i p i d s showed an increased content of the C12 and C14 acids,pointing to an increased r a t e of f a t t y a c i d synthesis. These f a t t y changes may be explained by the s p e c i f i c l o c a l i z a t i o n of PEP-CK i n man: f o r 80% i n the mitochondria. I n t h e absence of PEP-CK overproduction of c i t r a t e may occur, which w i l l leave the mitochondria i n exchange f o r malate, giving r i s e t o the operation of a " c i t r a t emalate" cycle. The net r e s u l t of such a cycle w i l l be the t r a n s f e r of acetyl-CoA to t h e cytoplasm where i t may serve as s u b s t r a t e f o r f a t t y a c i d synthetase.
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Antibody a c t i v a t i o n o f mutant fructaldolase. ~n t i h d i e s t h a t a r e s p e c i f i c f o r an enzyme may i n t e r f e r e w i t h i t s c a t a l y t i c a c t i v i t y : i n h i b i t i o n o f t h e enzyme may occur b u t a c t i v a t i o n can a l s o t a k e place.
Antibodies r a i s e d a g a i n s t c e r t a i n w i l d t y p e enzymes o f b a c t e r i a and f u n g i have been found t o a c t i v a t e some g e n e t i c mutants o f t h e same enzymes. W e would l i k e t o r e p o r t t h e f i r s t antibody a c t i v a t i o n o f a mutant human enzyme observed i n v i t r o . E x t r a c t s o f l i v e r biopsy specimens from 5 c h i l d r e n w i t h h e r e d i t a r y f r u c t o s e i n t o l e r a n c e (HFI) were examined f o r f r u c t a l d o l a s e a c t i v i t y .
T y p i c a l r e d u c t i o n o f t h e c a t a l y t i c a c t i v i t y as w e l l as reduced thermal s t a b i l i t y o f f r u c t a l d o l a s e were demonstrated.
When t h e e x t r a c t s were r e a c t e d w i t h antiserum a g a i n s t human l i v e r f r u c t a l d o l a s e 0 , up t o t h r e e -f o l d a c t i v a t i o n o f fructose-l-phosphate a l d o l a s e was observed i n 3 o u t o f 5 samples. T h i s observation i n d i c a t e s g e n e t i c h e t e r o g e n e i t y amongst HFI p a t i e n t s and perhaps more i m p o r t a n t l y , i t lends support t o t h e s p e c u l a t i o n t h a t some day a t l e a s t i n some human mutants engineering o f t h e mutant enzyme may become p o s s i b l e . The administration of fructose (F) t o pat i e n t s with hereditary fructose intolerance induces a profound hypoglycemia 14hich i s not relieved by glucagon. This lack of response was t e n t a t i v e l y a t t r i b u t e d t o t h e p a r t i a l (70 %) inh i b i t i o n of phosphorylase a by F-1-P (Biochem. J. 134, 637, 1973) .
'The administration o f tagatose (T) t o r a t s produces changes t h a t a r e s i m i l a r t o those induced by F (accumulation o f ketose 1-P, depletion of ATP and P i ) , but l a s t longer due t o t h e s l ower metabolism of T. In controls, t h e SC admin i s t r a t i o n of glucagon (0.1 mg/kg) provoked a 60 % r i s e o f hepatic glucose and a 3-fold r i s e o f glucose 6-P a f t e r 1 0 min. In r a t s t r e a t e d with T (2 gjkg IP) 10 min before glucago-., hoth increases were completely abolished notwlthstanding a normal a c t i v a t i o n of phosphorylase. This indicates a conplete i n h i b i t i o n of phosphorylas e a i n vivo. The inhibitory e f f e c t of T-1-P on p u r i f i e d l i v e r phosphorylase a was, however, not more pronounced than hhat of F-1-P.
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